286 related articles for article (PubMed ID: 15370723)
1. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial.
Pallay RM; Seger W; Adler JL; Ettlinger RE; Quaidoo EA; Lipetz R; O'Brien K; Mucciola L; Skalky CS; Petruschke RA; Bohidar NR; Geba GP
Scand J Rheumatol; 2004; 33(4):257-66. PubMed ID: 15370723
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study.
Zerbini C; Ozturk ZE; Grifka J; Maini M; Nilganuwong S; Morales R; Hupli M; Shivaprakash M; Giezek H;
Curr Med Res Opin; 2005 Dec; 21(12):2037-49. PubMed ID: 16368055
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
Birbara CA; Puopolo AD; Munoz DR; Sheldon EA; Mangione A; Bohidar NR; Geba GP;
J Pain; 2003 Aug; 4(6):307-15. PubMed ID: 14622687
[TBL] [Abstract][Full Text] [Related]
4. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.
Wilkens P; Scheel IB; Grundnes O; Hellum C; Storheim K
JAMA; 2010 Jul; 304(1):45-52. PubMed ID: 20606148
[TBL] [Abstract][Full Text] [Related]
5. Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain.
Sheldon EA; Bird SR; Smugar SS; Tershakovec AM
Spine (Phila Pa 1976); 2008 Mar; 33(5):533-8. PubMed ID: 18317199
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
[TBL] [Abstract][Full Text] [Related]
8. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico.
Ramos-Remus CR; Hunsche E; Mavros P; Querol J; Suarez R
Curr Med Res Opin; 2004 May; 20(5):691-8. PubMed ID: 15140335
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
[TBL] [Abstract][Full Text] [Related]
12. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib.
Jensen MP; Schnitzer TJ; Wang H; Smugar SS; Peloso PM; Gammaitoni A
Clin J Pain; 2012 Jan; 28(1):1-7. PubMed ID: 21705875
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
Hale ME; Ahdieh H; Ma T; Rauck R;
J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
Puopolo A; Boice JA; Fidelholtz JL; Littlejohn TW; Miranda P; Berrocal A; Ko A; Cichanowitz N; Reicin AS
Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
[TBL] [Abstract][Full Text] [Related]
16. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.
Greenwald M; Peloso PM; Mandel D; Soto O; Mehta A; Frontera N; Boice JA; Zhan XJ; Curtis SP
Curr Med Res Opin; 2011 Oct; 27(10):2033-42. PubMed ID: 21905970
[TBL] [Abstract][Full Text] [Related]
17. Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
Viscusi ER; Frenkl TL; Hartrick CT; Rawal N; Kehlet H; Papanicolaou D; Gammaitoni A; Ko AT; Morgan LM; Mehta A; Curtis SP; Peloso PM
Curr Med Res Opin; 2012 Aug; 28(8):1323-35. PubMed ID: 22738802
[TBL] [Abstract][Full Text] [Related]
18. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
Rubin BR; Burton R; Navarra S; Antigua J; Londoño J; Pryhuber KG; Lund M; Chen E; Najarian DK; Petruschke RA; Ozturk ZE; Geba GP
Arthritis Rheum; 2004 Feb; 50(2):598-606. PubMed ID: 14872504
[TBL] [Abstract][Full Text] [Related]
20. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial.
Steffens JP; Santos FA; Pilatti GL
J Periodontol; 2011 Sep; 82(9):1238-44. PubMed ID: 21235334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
